Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 4
2004 2
2005 1
2006 6
2007 2
2008 3
2009 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 2
2016 1
2017 1
2018 4
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study.
Barin L, Kaufmann M, Salmen A, Kamm CP, Gobbi C, Kuhle J, Pot C, Chan A, Czaplinski A, Ajdacic-Gross V, Rodgers S, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry. Barin L, et al. Among authors: czaplinski a. Mult Scler Relat Disord. 2019 Feb;28:17-25. doi: 10.1016/j.msard.2018.11.033. Epub 2018 Dec 2. Mult Scler Relat Disord. 2019. PMID: 30530118
Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey.
Kamm CP, Muehl S, Mircsof D, Müller S, Czaplinski A, Achtnichts L, Stellmes P, Di Virgilio G. Kamm CP, et al. Among authors: czaplinski a. Front Neurol. 2018 Oct 10;9:821. doi: 10.3389/fneur.2018.00821. eCollection 2018. Front Neurol. 2018. PMID: 30364133 Free PMC article.
Stem cells for ALS: An overview of possible therapeutic approaches.
Czarzasta J, Habich A, Siwek T, Czapliński A, Maksymowicz W, Wojtkiewicz J. Czarzasta J, et al. Among authors: czaplinski a. Int J Dev Neurosci. 2017 Apr;57:46-55. doi: 10.1016/j.ijdevneu.2017.01.003. Epub 2017 Jan 11. Int J Dev Neurosci. 2017. PMID: 28088365 Review.
Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis.
Wehrum T, Beume LA, Stich O, Mader I, Mäurer M, Czaplinski A, Weiller C, Rauer S. Wehrum T, et al. Among authors: czaplinski a. Neurology. 2018 Feb 13;90(7):e601-e605. doi: 10.1212/WNL.0000000000004950. Epub 2018 Jan 19. Neurology. 2018. PMID: 29352101
Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis.
Zecca C, Roth S, Findling O, Perriard G, Bachmann V, Pless ML, Baumann A, Kamm CP, Lalive PH, Czaplinski A. Zecca C, et al. Among authors: czaplinski a. Eur J Neurol. 2018 May;25(5):762-767. doi: 10.1111/ene.13594. Epub 2018 Mar 6. Eur J Neurol. 2018. PMID: 29431876 Free PMC article. Clinical Trial.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Zörner B, Filli L, Reuter K, Kapitza S, Lörincz L, Sutter T, Weller D, Farkas M, Easthope CS, Czaplinski A, Weller M, Linnebank M. Zörner B, et al. Among authors: czaplinski a. Mult Scler. 2016 Oct;22(11):1463-1475. doi: 10.1177/1352458515622695. Epub 2016 Jan 13. Mult Scler. 2016. PMID: 26762672 Free article. Clinical Trial.
[Tic syndrome].
Czapliński A, Steck AJ, Fuhr P. Czapliński A, et al. Neurol Neurochir Pol. 2002 May-Jun;36(3):493-504. Neurol Neurochir Pol. 2002. PMID: 12185806 Review. Polish.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Ramseier SP, Roth S, Czaplinski A. Ramseier SP, et al. Among authors: czaplinski a. BMC Pharmacol Toxicol. 2015 Apr 1;16:7. doi: 10.1186/s40360-015-0006-0. BMC Pharmacol Toxicol. 2015. PMID: 25889400 Free PMC article. Clinical Trial.
Solitary tumour-like mass lesions of the central nervous system: Primary angiitis of the CNS and inflammatory pseudotumour.
Killeen T, Jucker D, Went P, Muthurajah V, Woon K, Cesnulis E, Czaplinski A. Killeen T, et al. Among authors: czaplinski a. Clin Neurol Neurosurg. 2015 Aug;135:34-7. doi: 10.1016/j.clineuro.2015.05.008. Epub 2015 May 16. Clin Neurol Neurosurg. 2015. PMID: 26010394 No abstract available.
Immune mediated neuropathies--an update on therapeutic strategies.
Czaplinski A, Steck AJ. Czaplinski A, et al. J Neurol. 2004 Feb;251(2):127-37. doi: 10.1007/s00415-004-0323-5. J Neurol. 2004. PMID: 14991345 Review.
34 results
Jump to page
Feedback